13-08-2019
Eckert & Ziegler: Strong Growth in Sales and Income
01-08-2019
Eckert & Ziegler forms joint venture for tumor irradiation devices in China
29-07-2019
Eckert & Ziegler: EZAG to set up radiopharmaceutical production facility in China
26-07-2019
Eckert & Ziegler: EMA Grants Drug Designation to EZAG Affiliate
22-07-2019, 19:19 CEST (Ad hoc press release)
Eckert & Ziegler Increases Profit Forecast to 4 Euro per Share
06-06-2019
Eckert & Ziegler will be admitted to SDax
29-05-2019
Eckert & Ziegler: Shareholders approve dividend of 1.20 EUR. Frank Perschmann joins Supervisory Board
14-05-2019
Eckert & Ziegler will be admitted to the MSCI Germany Small Cap Index
07-05-2019
Eckert & Ziegler off to a strong start in 2019
11-04-2019
Merger between Eckert & Ziegler BEBIG SA (BEBIG) and Eckert & Ziegler Strahlen – und Medizintechnik AG (EZAG) - Completion of the sale of the full EZAG Exchange Shares resulting from the partial rights further to the merger
05-04-2019
Eckert & Ziegler delivers a record result
02-04-2019
Eckert & Ziegler will be admitted to the MSCI Germany Small Cap Index
26-03-2019, 18:58 CET (Ad hoc press release)
Eckert & Ziegler Increases Dividend
20-03-2019
Eckert & Ziegler Awarded for Excellent Training Quality
18-02-2019
Eckert & Ziegler: Merger with Belgian Eckert & Ziegler BEBIG SA Successfully Completed
21-01-2019, 12:44 CET (Ad hoc press release)
Eckert & Ziegler 2018: Revenue and earnings higher than expected
